Research interests
ACL ADVANTAGE AF grant awarded by Boston Scientific Corporation[9]
2024 to 2026
Sean Pokorney
As of 2026 · Last known relationship
As of 2026 · Last known relationship
Sean Pokorney is a Duke cardiologist and electrophysiologist whose work connects arrhythmia care, cardiac devices, and health-system quality improvement. He is an Assistant Professor of Medicine and a member of the Duke Clinical Research Institute. His training includes an M.D. and M.B.A. from Northwestern University, internal medicine residency there, and cardiovascular disease, clinical research, and electrophysiology fellowships at Duke from 2011 to 2017. His scholarship addresses atrial fibrillation treatment pathways, anticoagulation access and adherence, supraventricular tachycardia, cardiac-monitor performance, pacing, and infected-device management. He helped guide the multidisciplinary WakeMed-Duke Health Lead Management Clinic established in February 2020 and presented COMPASS primary results at the 2026 Heart Rhythm Society Scientific Sessions.
Each topic is linked to its supporting source in Sources.
Training includes Discussed the COMPASS early-rhythm-control intervention in a Heart Rhythm TV interview following its HRS 2026 presentation, Presented primary results of the COMPASS Heart Rhythm Society quality-improvement initiative at the HRS 2026 Scientific Sessions, Electrophysiology Fellowship at Duke University, School of Medicine, and Clinical Research Fellowship at Duke University, School of Medicine, Duke Clinical Research Institute, plus 11 more records.
Explore education and trainingAs of 2026
As of 2026
As of 2017
As of 2015
As of 2015
As of 2011
As of 2008
As of 2008
As of 2020
As of 2019
ACL ADVANTAGE AF grant awarded by Boston Scientific Corporation[9]
2024 to 2026
AFIB Preceptorship Immersion Learning Lab grant awarded by Novartis Pharmaceuticals Corporation[9]
2026
AVANT GUARD grant awarded by Boston Scientific Corporation[9]
2024 to 2028
Center-Level Factors and Geographic Variation in Treatment of Cardiovascular Implantable Electronic Device Infections[9]
From 2026
Centers of Excellence Optimal Management Pathways for Atrial Fibrillation Specialty Services (COMPASS) early rhythm control treatment care pathway: A quality improvement initiative[9]
From 2026
COMPASS grant awarded by the Heart Rhythm Society[9]
2023 to 2026
Emergency Department Visits in the United States for Paroxysmal Supraventricular Tachycardia Are Increasing Among Adults: An Analysis from the Nationwide Emergency Department Sample[9]
From 2026
Grant awarded by the University of North Carolina - Chapel Hill for improving outpatient comprehensive atrial fibrillation care through direct primary care engagement[9]
2024
ICD-in-HFmrEF Virtual Trial analyses grant awarded by Medtronic, Inc.[9]
2023 to 2026
Independent Core Lab grant awarded by Biotronik, Inc.[9]
2025 to 2026
LUX-DX Insertable Cardiac Monitor independent event analysis grant awarded by Boston Scientific Corporation[9]
2023 to 2025
LUX PERFORM grant awarded by Boston Scientific Corporation[9]
2021 to 2025
Medicare coverage gap status, adherence to oral anticoagulation, and stroke rates in patients with atrial fibrillation[9]
From 2026
Off-Label Dapagliflozin After Atrial Fibrillation Ablation: A Reasonable Intervention or Overstretching the Evidence?[9]
From 2026
Patient Care Pathways and Outcomes Following Newly Diagnosed Atrial Fibrillation[9]
From 2026
REview and improvement of cardiac implanTable device Infection management qualitY initiative (RECTIFY): Rationale and design for a cardiac implantable electronic device infection quality initiative demonstration project[9]
From 2026
Safety, performance, and remote programming utilization of an insertable cardiac monitor: The LUX-Dx PERFORM study[9]
From 2026
Same-Day Discharge in Ventricular Ablation: Safety Outcomes and Case Selection[9]
From 2026
Sex-Based Differences in Left Bundle Branch Capture During Left Bundle Branch Area Pacing[9]
From 2026